EORTC Extends Its Partnership with Medidata to Enhance Oncology Research
EORTC, a leading cancer research organization, has announced an extension of its partnership with Medidata. This collaboration is focused on enhancing oncology research and improving the patient experience in clinical trials.
Medidata technology will be deployed to increase access to clinical trials and transform how patients engage with their treatment pathways. EORTC aims to leverage these advanced tools to optimize data management and streamline research protocols.
As part of this initiative, both EORTC and Medidata will work together to develop innovative solutions that address current challenges in oncology trials.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.